Profile
Jeffrey H.
Knapp served as Chief Executive Officer & Director at DNAtrix, Inc. He was also Senior Vice President-Sales & Marketing at Abgenix, Inc. and VP-North American Sales & Marketing at Pharmion Corp.
Knapp served as Chief Operating Officer at Adamas Pharmaceuticals LLC and Affymax, Inc. He was also Vice President-US Sales & Marketing at EMD Pharmaceuticals, Inc. Knapp served as Chief Operating Officer at Aimmune Therapeutics, Inc. Knapp completed his undergraduate degree from Wittenberg University.
Former positions of Jeffrey H. Knapp
| Companies | Position | End |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Chief Operating Officer | 01/07/2018 |
| ADAMAS PHARMACEUTICALS, INC. | Chief Operating Officer | 29/01/2016 |
| AFFYMAX, INC. | Corporate Officer/Principal | 18/03/2013 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Sales & Marketing | 01/04/2006 |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Sales & Marketing | 01/07/2005 |
Training of Jeffrey H. Knapp
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
Affymax, Inc.
Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Wittenberg University
Wittenberg University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
- Stock Market
- Insiders
- Jeffrey H. Knapp
















